AMERICANN, INC. (OTCMKTS:ACAN) Files An 8-K Other EventsItem 8.01.
On June 5, 2017 AmeriCann released Campanelli Companies, the general contractor, and CBRE, AmeriCann’s project management team, to begin preliminary site work on AmeriCann’s Massachusetts Medical Cannabis Center (MMCC). The scope of the work will include site clearing, fence installation, project signage, delivery of a project construction trailer and installation of a “construction cam” to allow interested parties to view project progress on AmeriCann’s website when the construction is operational.
AmeriCann’s flagship project, the Massachusetts Medical Cannabis Center, is 47 miles from Boston in the midst of the rapidly growing Massachusetts medical cannabis market. The MMCC project is approved for 1 million square feet, which will be developed in phases and is expected to be one of the most technologically advanced cultivation facilities in the nation.
About AMERICANN, INC. (OTCMKTS:ACAN)
AmeriCann, Inc. develops, owns and supports medical cannabis cultivation and processing facilities. The Company has a multi-market portfolio of over 1,000,000 square feet of cannabis production infrastructure in various stages of development, which consists of approximately 125,000 square feet of approved cultivation and processing infrastructure on over five acres located at 5280 Monaco St. in Denver, and site approval for approximately 977,000 square feet of cultivation, processing and administration infrastructure at the Massachusetts Medical Cannabis Center (MMCC). To support local businesses that seek to serve cannabis patients in their communities, the Company initiated the AmeriCann Preferred Partner Program. The initial step in becoming a preferred partner involves an application on its Website. The Company focuses on leasing facilities to its Preferred Partners that will be designed with its cultivation and processing system called Cannopy.